What Medline's FY2025 10-K says: 12 signals
Medline filed its latest 10-K with the SEC on Feb 25, 2026. It discusses restructuring, supply chain disruption and acquisition completed.
Public (MDLN)Medical Equipment Manufacturing10,000+ employeesmedline.comLinkedIn
- Filed
- Feb 25, 2026
- Period
- FY2025
- Fiscal year end
- 12/31
- Filings
- 1
10-K · latest 10
What Medline's 10-K filings say
- SEC EDGAR
10-K · FY2025
Filed · Fiscal year ends 12/31 · 12 signals
Raised ~$7.05B in net proceeds from December 2025 IPO
Medline completed its IPO in December 2025, generating approximately $7.05 billion in net proceeds.
$7B
net proceeds from IPO
Tariffs caused a $290M adverse impact in 2025, with a $200M incremental impact expected in 2026.
Medline is facing significant financial pressure from global trade tariffs, with a $290 million hit to pre-tax income in 2025 and a projected $200 million incremental impact in 2026.
$290M
net adverse impact to income before taxes from tariffs for the year ended December 31, 2025
Medline completed acquisitions of Ecolab's Microtek business and Sinclair Dental in 2024.
Ecolab, Inc.
Facing $200M incremental adverse impact from tariffs in FY2026
Tariffs are projected to reduce income before taxes by an additional $200M in 2026, on top of a $290M hit in 2025.
$200M
estimated incremental adverse impact to income before taxes from tariffs
Medline has a major initiative to convert customers from 3rd-party brands to its own Medline Brand.
This creates needs for customer analytics, sales enablement tools, and marketing automation to drive this strategic conversion.
65%
Supply Chain Solutions (third-party) product mix in Prime Vendor agreements
Recent Dec 2025 IPO creates new public company costs and Sarbanes-Oxley compliance needs.
Following its December 2025 IPO, Medline is facing new, significant costs and compliance burdens related to operating as a public company, including Sarbanes-Oxley.
Acquired Ecolab's surgical business and Sinclair Dental, driving post-merger integration needs.
The 2024 acquisitions of Ecolab's Microtek surgical solutions business and Sinclair Dental will require Medline to integrate disparate operations, supply chains, and IT systems.
Ecolab, Inc.Sinclair Dental Co. Ltd
Medline expands into Canadian dental market via acquisition of Sinclair Dental.
The acquisition of Canada's largest independent dental distributor marks a strategic entry into a new market segment and geography, requiring investment in Canadian-specific logistics, sales operations, and regulatory compliance.
Medline reports material impact from inflation on sourcing, production, and distribution costs.
Inflation is directly increasing the cost to source materials, produce goods, and distribute products to customers.
Company facing supply chain disruptions from raw material shortages and third-party supplier issues.
Medline's operations are being negatively impacted by both raw material shortages and issues with its third-party suppliers.
Showing 10 of 12 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Medline with the Signal API
One POST /v1/companies/enrich call with medline.com returns Medline 10-K signals (sec-10k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"medline.com","signal_types":["sec-10k"],"limit":20}'Same industry
10-K at related companies
Questions about Medline 10-K
When did Medline file its latest 10-K?
What does Medline's latest 10-K say about debt refinancing?
Where can I find Medline's annual report?
Source. Annual reports (Form 10-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .